FindTrial
Sign In

Effects of electrostimulation in patients with chronic pain from HIV

Effects of Interferential Current upon HIV neuropathic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4cwps2
Enrollment
Unknown
Registered
2020-06-23
Start date
2014-03-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Neuropathy

Interventions

Interferential Current (IFC) (n=18) regulated in a 4000 Hz, modulated at 100 Hz (AMF), ranging 50 Hz (?F AMF) to not cause stimuli accommodation, with a delivery ramp of 1:5:1 (SLOPE). IFC was applied
Device
E02.331

Sponsors

Universidade La Salle
Lead Sponsor
Universidade La Salle
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women with HIV/AIDS; aged between 18 and 65 years; in antiretroviral therapy; have neuropathic cervicalgia, confirmed by LANSS scale.

Exclusion criteria

Exclusion criteria: Active contagious infection (meningitis, pulmonary tuberculosis); history of chronic diseases associated with neuropathic pain (diabetes, lupus, rheumatoid arthritis, infection by Human T-cell Lymphotropic Virus); chronic renal or peripheral vascular insufficiency; oncologic disease; severe disease that limits the understanding of the informed consent or tests

Design outcomes

Primary

MeasureTime frame
Pain Pressure Threshold improvement, verified with an electronic pressure algometer (Somedic AB, Stockholm, Sweden), used to determine maximum tolerable pressure on the cervical surface (local effect), in the forearm and anterior tibial muscle (peripheral effect), through an improvement of a P<0.05;Outcome found: P smaller than 0.05 in active group in cervical surface, forearm and anterior tibial muscle.—

Secondary

MeasureTime frame
Pain improvement, through Visual Analogue Scale for Pain (VAS), through an improvement of a P<0.05;Sleep quality improvement, measured through the Pittsburgh Sleep Quality Index (PSQI), through an improvement of a P<0.05;Pain catastrophic thought improvement, through iPain Catastrophizing Scale (PCS), through an improvement of a P<0.05;Pain outcome found: Pain improvement in patients with sham and active.;Sleep outcome found: There was no significant difference in groups in pre and post treatment.;Catastrophism outcome found: There was no significant difference in groups in pre and post treatment.—

Countries

Brazil

Contacts

Public ContactAndressa Souza

Universidade La Salle

andressasz@gmail.com+55-51-981975718

Outcome results

None listed

Source: REBEC (via WHO ICTRP)